IMMUNOTECH-B 06978·

ROE -----16.20%---64.40%48.20%-----43.08%---62.57%19.49%-192.85%130.28%1405.78%1598.63%1657.10%251.33% ROA -----------------32.31%---36.51%4.21%-39.64%3.13%-33.21%6.43%-38.30%5.08% Attributable profit growth ---------212.95%----------10.20%---5.25%15.45%44.18%49.43%-23.47%67.65% Debt-to-assets ----------------25.01%--42.42%17.41%79.81%37.39%102.92%23.11%102.85%0.06% Current ratio ----9.76--1.498.27----2.29--0.571.720.400.160.200.200.350.15 Operating cash flow / net profit ----1.26--0.880.39----0.72--0.560.150.490.080.670.180.420.25

Attributable profit growth ----45.88%-- Current ratio ----0.22-- Operating cash flow / net profit ----0.93--

Other income and gains ----8.08M--6.32M21.79%----17.75M--9.09M48.82%10.55M16.07%33.79M220.36%20.51M39.31% Administrative expenses ----11.67M--27.76M137.96%----104.25M--97.71M6.28%53.22M45.53%44.54M16.31%41.04M7.87% Net finance costs ----1.14M--2.07M82.38%----3.68M--6.13M66.80%8.52M38.86%7.49M12.04%6.81M9.16% Income tax ----0--0------------------926.00K------ Operating profit -----33.75M---106.98M216.96%-----350.94M---314.96M10.25%-326.96M3.81%-178.92M45.28%-224.10M25.25% Profit before tax -----34.89M---109.05M212.58%-----354.62M---321.10M9.45%-335.48M4.48%-186.42M44.43%-230.91M23.87% Net profit -----34.89M---109.05M212.58%-----354.62M---321.10M9.45%-335.48M4.48%-187.34M44.16%-230.91M23.25% Net profit attributable to owners -----34.77M---108.80M212.95%-----354.22M---318.11M10.20%-334.82M5.25%-186.91M44.18%-230.78M23.47%

Other income and gains -51.05M--10.63M120.83% Selling and distribution expenses 0--59.00K-- Administrative expenses 19.64M--17.05M13.22% Income tax 2.00K--2.00K0.00% Profit before tax -129.03M---69.87M45.85% Net profit -129.03M---69.87M45.85% Net profit attributable to owners -129.10M---69.87M45.88%

Cash and cash equivalents ----128.33M--282.25M119.94%------------52.16M--46.96M9.98%54.46M15.97% Inventories ----2.29M--4.81M109.95%------------------------ Total current assets ----185.76M--308.15M65.89%----412.20M--118.11M71.35%213.89M81.09%87.49M59.09%171.59M96.12% Total assets ----------------1.10B--879.44M19.88%846.28M3.77%564.04M33.35%602.94M6.90% Total current liabilities ----19.02M--206.17M983.74%----180.10M--208.47M15.75%530.27M154.36%430.21M18.87%490.85M14.10% Total liabilities ----------------274.51M--373.07M35.90%675.39M81.04%580.50M14.05%620.14M6.83% Equity attributable to owners ----214.65M--168.94M21.29%----822.26M--508.44M38.17%173.62M65.85%-13.30M107.66%-13.93M4.75% Total equity ----216.30M--170.34M21.25%----823.18M--506.37M38.49%170.89M66.25%-16.45M109.63%-17.21M4.58%

Total current assets ----100.13M-- Total current liabilities ----448.42M-- Total liabilities -----87.08M-- Equity attributable to owners -----83.79M-- Total equity -----87.08M--

Net cash from operating activities -----44.08M---95.47M116.59%-----254.65M---180.92M28.95%-163.63M9.56%-125.74M23.15%-97.29M22.63% Net cash from investing activities -----50.40M--25.74M151.07%-----328.21M--23.38M107.12%-116.60M598.68%141.10M221.02%-98.07M169.50% Net cash from financing activities ----214.45M--217.21M1.29%-----11.00M---36.06M227.85%273.92M859.63%-20.59M107.52%203.20M1086.98% Net change in cash ----119.97M--147.48M22.93%-----593.86M---193.60M67.40%-6.30M96.74%-5.23M17.08%7.84M249.99%

Net cash from operating activities -----65.25M--